Chemically functionalized single-walled carbon nanotubes (SWNTs) have shown promise in tumor targeted accumulation in mice and exhibit biocompatibility, excretion and little toxicity. Here, we demonstrate in-vivo SWNT drug delivery for tumor suppression in mice. We conjugate paclitaxel (PTX), a widely used cancer chemotherapy drug to branched polyethylene-glycol (PEG) chains on SWNTs via a cleavable ester bond to obtain a water soluble SWNT-paclitaxel conjugate (SWNT-PTX). SWNT-PTX affords higher efficacy in suppressing tumor growth than clinical Taxol in a murine 4T1 breast-cancer model, owing to prolonged blood circulation and 10-fold higher tumor PTX uptake by SWNT delivery likely through enhanced permeability and retention (EPR). Drug molecules carried into the reticuloendothelial system are released from SWNTs and excreted via biliary pathway without causing obvious toxic effects to normal organs. Thus, nanotube drug delivery is promising for high treatment efficacy and minimum side effects for future cancer therapy with low drug doses.
Clinically Ready Magnetic Microrobots for Targeted Therapies
Magnebotix AG(Magnebotix公司);University of Würzburg(维尔茨堡大学);University of Thessaly(色萨利大学);University of Barcelona(巴塞罗那大学);Institució Catalana de Recerca i Estudis Avançats (ICREA)(加泰罗尼亚研究与高等教育学院);Porto University(波尔图大学);Fudan University(复旦大学);Yiwu Research Institute of Fudan University(复旦大学义乌研究院);University Hospital of Zurich(苏黎世大学医院);University of Zurich(苏黎世大学);University Children's Hospital Zurich(苏黎世大学儿童医院);Kantonsspital Aarau AG(阿尔高州立医院);University Hospital Zurich(苏黎世大学医院)